05:12 AM EDT, 10/23/2025 (MT Newswires) -- Sanofi ( SNY ) said Thursday it plans to deploy artificial intelligence to streamline clinical trial operations, unify workflows, and improve data quality.

The company expanded its 10-year-plus partnership with Medidata, saying its Experiences platform addresses the "fragmented, standalone tools of the life sciences industry."

The AI tools can amplify the development of therapies with "greater precision and impact," Sanofi ( SNY ) added.

Financial details of the deal were not disclosed.